Notice of General Meeting/Proxy Form
Released
Released
Announcement PDF
Patrys Limited
(ACN 123 055 363)
NOTICE OF GENERAL MEETING AND EXPLANATORY
MEMORANDUM
Monday, 19 January 2026
11:00AM (AWST)
To be held in person at
Templar, Level 1, 1205 Hay Street, West Perth WA 6005
This Notice of General Meeting and Explanatory Memorandum should be read in its entirety. If
Shareholders are in doubt as to how to vote, they should seek advice from their accountant, solicitor
or other professional adviser without delay.
Should you wish to discuss any matter please do not hesitate to contact the Company by telephone
on +61 8 6165 8858.
NOTICE OF MEETING
Notice is given that the General Meeting of Shareholders of Patrys Limited (ACN 123 055 363)
(Company) will be held in person at Templar, Level 1, 1205 Hay Street, West Perth WA 6005 on
Monday, 19 January 2026 commencing at 11:00AM (AWST) (Meeting).
The Explanatory Memorandum to this Notice provides additional information on matters to be
considered at the Meeting. The Explanatory Memorandum and the Proxy Form, form part of this
Notice.
The Directors have determined pursuant to regulation 7.11.37 of the Corporations Regulations 2001
(Cth) that the persons eligible to vote at the Meeting are those who are registered as Shareholders
at 11:00AM AWST on Saturday, 17 January 2026.
Terms and abbreviations used in this Notice and Explanatory Memorandum are defined in
Schedule 1.
AGENDA
1. Resolution 1 – Approval to issue Consideration Shares
To consider and, if thought fit, to pass, with or without amendment, the following resolution
as an ordinary resolution:
“Subject to and conditional upon the Acquisition resolutions being passed by Shareholders,
that, for the purposes of Listing Rule 7.1 and for all other purposes, approval is given for the
Company to issue up to 110,000,000 Consideration Shares, on the terms and conditions set
out in the Explanatory Memorandum.”
Voting Exclusion Statement
The Company will disregard any votes cast in favour of the Resolution by or on behalf of:
(a) a person who is expected to participate in, or who will obtain a material benefit as a result of the proposed
issue (except a benefit solely by reason of being a holder of ordinary securities in the Company) (namely,
the Vendors (and/or their respective nominees)); or
(b) an Associate of that person or those persons.
However, this does not apply to a vote cast in favour of the Resolution by:
(a) a person as proxy or attorney who is entitled to vote on the Resolution, in accordance with directions
given to the proxy or attorney to vote on the Resolution in that way; or
(b) the Chair of the meeting as proxy or attorney for a person who is entitled to vote on the Resolution, in
accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or
(c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary
provided the following conditions are met:
(i) the beneficiary provides written confirmation to the holder that the beneficiary is not excluded
from the voting, and is not an associate of a person excluded from voting, on the Resolution;
and
(ii) the holder votes on the Resolution in accordance with directions given by the beneficiary to the
holder to vote in that way.
3
2. Resolution 2 – Approval to issue Performance Rights
To consider and, if thought fit, to pass with or without amendment, the following resolution as
an ordinary resolution:
“Subject to and conditional upon the Acquisition Resolutions being passed by Shareholders,
that, for the purposes of Listing Rule 7.1 and for all other purposes, approval is given for the
Company to issue up to 70,000,000 Performance Rights, on the terms and conditions set out
in the Explanatory Memorandum.”
Voting Exclusion Statement
The Company will disregard any votes cast in favour of the Resolution by or on behalf of:
(a) a person who is expected to participate in, or who will obtain a material benefit as a result of the proposed
issue (except a benefit solely by reason of being a holder of ordinary securities in the Company) (namely,
the Majority Vendors (and/or their respective nominees)); or
(b) an Associate of that person or those persons.
However, this does not apply to a vote cast in favour of the Resolution by:
(a) a person as proxy or attorney who is entitled to vote on the Resolution, in accordance with directions
given to the proxy or attorney to vote on the Resolution in that way; or
(b) the Chair of the meeting as proxy or attorney for a person who is entitled to vote on the Resolution, in
accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or
(c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary
provided the following conditions are met:
(i) the beneficiary provides written confirmation to the holder that the beneficiary is not excluded
from the voting, and is not an associate of a person excluded from voting, on the Resolution;
and
(ii) the holder votes on the Resolution in accordance with directions given by the beneficiary to the
holder to vote in that way.
3. Resolution 3 – Approval of Convertible Notes and issue of
Shares (on conversion)
To consider and, if thought fit, pass with or without amendment, the following resolution as
an ordinary resolution:
“Subject to and conditional upon the Acquisition Resolutions being passed by Shareholders,
that, for the purposes of Listing Rule 7.1 and for all other purposes, approval is given for the
Company to accept the novation of the Convertible Notes and effectively issue up to
25,000,000 convertible notes totalling A$300,000 face value entitling the holders to convert
the convertible notes into 25,000,000 fully paid ordinary shares in the Company on the terms
and conditions set out in the Explanatory Memorandum.”
Voting Exclusion Statement
The Company will disregard any votes cast in favour of the Resolution by or on behalf of:
(a) a person who is expected to participate in, or who will obtain a material benefit as a result of the proposed
issue (except a benefit solely by reason of being a holder of ordinary securities in the Company) (namely,
the Noteholders(and/or their respective nominees)); or
(b) an Associate of that person or those persons.
However, this does not apply to a vote cast in favour of the Resolution by:
(a) a person as proxy or attorney who is entitled to vote on the Resolution, in accordance with directions
given to the proxy or attorney to vote on the Resolution in that way; or
(b) the Chair of the meeting as proxy or attorney for a person who is entitled to vote on the Resolution, in
accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or
4
(c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary
provided the following conditions are met:
(i) the beneficiary provides written confirmation to the holder that the beneficiary is not excluded
from the voting, and is not an associate of a person excluded from voting, on the Resolution;
and
(ii) the holder votes on the Resolution in accordance with directions given by the beneficiary to the
holder to vote in that way.
4. Resolution 4 – Approval to issue Vendor Facilitation Shares
To consider and, if thought fit, pass with or without amendment, the following resolution as
an ordinary resolution:
“Subject to and conditional upon the Acquisition Resolutions being passed by Shareholders,
that, for the purposes of Listing Rule 7.1 and for all other purposes, approval is given for the
Company to issue up to 50,000,000 Vendor Facilitation Shares on the terms and conditions
set out in the Explanatory Memorandum.”
Voting Exclusion Statement
The Company will disregard any votes cast in favour of the Resolution by or on behalf of:
(a) a person who is expected to participate in, or who will obtain a material benefit as a result of the proposed
issue (except a benefit solely by reason of being a holder of ordinary securities in the Company) (namely,
the Vendor Facilitators (and/or their respective nominees)); or
(b) an Associate of that person or those persons.
However, this does not apply to a vote cast in favour of the Resolution by:
(a) a person as proxy or attorney who is entitled to vote on the Resolution, in accordance with directions
given to the proxy or attorney to vote on the Resolution in that way; or
(b) the Chair of the meeting as proxy or attorney for a person who is entitled to vote on the Resolution, in
accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or
(c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary
provided the following conditions are met:
(i) the beneficiary provides written confirmation to the holder that the beneficiary is not excluded
from the voting, and is not an associate of a person excluded from voting, on the Resolution;
and
(ii) the holder votes on the Resolution in accordance with directions given by the beneficiary to the
holder to vote in that way.
5. Resolution 5 – Approval to issue Incentive Options to
Director (Mr Brian Leedman)
To consider and, if thought fit, pass with or without amendment, the following resolution as
an ordinary resolution:
“That, for the purposes of Listing Rule 10.11 and for all other purposes, approval is given for
the Company to issue up to 5,000,000 Incentive Options to Mr Brian Leedman (and/or his
nominees) on the terms and conditions set out in the Explanatory Memorandum.”
Voting Exclusion Statement
The Company will disregard any votes cast in favour of:
(a) Mr Brian Leedman (and/or his nominees) and any other person who will obtain a material benefit as a
result of the issue of the securities (except a benefit solely by reason of being a holder of ordinary
securities in the entity);
(b) any Associate of that person or those persons.
5
However, this does not apply to a vote cast in favour of the Resolution by:
(a) a person as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with
directions given to the proxy or attorney to vote on the Resolution in that way; or
(b) the Chair as proxy or attorney for a person who is entitled to vote on the Resolution, in accordance with
a direction given to the Chair to vote on the Resolution as the Chair decides; or
(c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary
provided the following conditions are met:
(i) the beneficiary provides written confirmation to the holder that the beneficiary is not excluded
from voting, and is not an associate of a person excluded from voting, on the Resolution; and
(ii) the holder votes on the Resolution in accordance with directions given by the beneficiary to the
holder to vote in that way.
Voting Prohibition Statement
In accordance with section 224 of the Corporations Act, a vote on the Resolution must not be cast (in any capacity)
by or on behalf of a related party to whom the Resolutions would permit a financial benefit to be given, or an
associate of such a related party (Resolution 5 Excluded Party). However, this prohibition does not apply if the
vote is cast by a person as proxy appointed by writing that specifies how the proxy is to vote on the Resolution
and it is not cast on behalf of a Resolution 5 Excluded Party.
In accordance with section 250BD of the Corporations Act, a person appointed as a proxy must not vote, on the
basis of that appointment, on the Resolution if:
(a) the proxy is either:
(i) a member of the Key Management Personnel; or
(ii) a Closely Related Party of such a member; and
(b) the appointment does not specify the way the proxy is to vote on the Resolution.
Provided the Chair is not a Resolution 5 Excluded Party, the above prohibition does not apply if:
(c) the proxy is the Chair; and
(d) the appointment expressly authorises the Chair to exercise the proxy even though the Resolution are
connected directly or indirectly with remuneration of a member of the Key Management Personnel.
6. Resolution 6 – Approval to issue Facilitation Shares
To consider and, if thought fit, pass with or without amendment, the following resolution as
an ordinary resolution:
“Subject to and conditional upon the Acquisition Resolutions being passed by Shareholders,
that, for the purposes of Listing Rule 7.1 and for all other purposes, approval is given for the
Company to issue up to 6,666,666 Facilitation Shares on the terms and conditions set out in
the Explanatory Memorandum.”
Voting Exclusion Statement
The Company will disregard any votes cast in favour of the Resolution by or on behalf of:
(a) a person who is expected to participate in, or who will obtain a material benefit as a result of the proposed
issue (except a benefit solely by reason of being a holder of ordinary securities in the Company) (namely,
the Facilitators (and/or their respective nominees)); or
(b) an Associate of that person or those persons.
However, this does not apply to a vote cast in favour of the Resolution by:
(a) a person as proxy or attorney who is entitled to vote on the Resolution, in accordance with directions
given to the proxy or attorney to vote on the Resolution in that way; or
(b) the Chair of the meeting as proxy or attorney for a person who is entitled to vote on the Resolution, in
accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or
6
(c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary
provided the following conditions are met:
(i) the beneficiary provides written confirmation to the holder that the beneficiary is not excluded
from the voting, and is not an associate of a person excluded from voting, on the Resolution;
and
(ii) the holder votes on the Resolution in accordance with directions given by the beneficiary to the
holder to vote in that way.
7. Resolution 7 – Approval to issue Corporate Adviser Shares
To consider and, if thought fit, pass with or without amendment, the following resolution as
an ordinary resolution:
“That, for the purposes of Listing Rule 7.1 and for all other purposes, approval is given for
the Company to issue up to 2,505,312 Corporate Adviser Shares on the terms and conditions
set out in the Explanatory Memorandum.”
Voting Exclusion Statement
The Company will disregard any votes cast in favour of the Resolution by or on behalf of:
(a) a person who is expected to participate in, or who will obtain a material benefit as a result of the proposed
issue (except a benefit solely by reason of being a holder of ordinary securities in the Company) (namely,
the Corporate Adviser (and/or its nominees)); or
(b) an Associate of that person or those persons.
However, this does not apply to a vote cast in favour of the Resolution by:
(a) a person as proxy or attorney who is entitled to vote on the Resolution, in accordance with directions
given to the proxy or attorney to vote on the Resolution in that way; or
(b) the Chair of the meeting as proxy or attorney for a person who is entitled to vote on the Resolution, in
accordance with a direction given to the Chair to vote on the Resolution as the Chair decides; or
(c) a holder acting solely in a nominee, trustee, custodial or other fiduciary capacity on behalf of a beneficiary
provided the following conditions are met:
(i) the beneficiary provides written confirmation to the holder that the beneficiary is not excluded
from the voting, and is not an associate of a person excluded from voting, on the Resolution;
and
(ii) the holder votes on the Resolution in accordance with directions given by the beneficiary to the
holder to vote in that way.
Dated 12 December 2025
BY ORDER OF THE BOARD
Johnathon Busing
Joint Company Secretary
7
EXPLANATORY MEMORANDUM
1. Introduction
This Explanatory Memorandum has been prepared for the information of Shareholders of the
Company in connection with the business to be conducted at the Meeting to be held in person
at Templar, Level 1, 1205 Hay Street, West Perth WA 6005 on Monday, 19 January 2026
commencing at 11:00 AM (AWST).
This Explanatory Memorandum should be read in conjunction with and forms part of the
accompanying Notice. The purpose of this Explanatory Memorandum is to provide
information to Shareholders in deciding whether or not to pass the Resolutions in the Notice.
A Proxy Form is located at the end of the Explanatory Memorandum.
2. Action to be taken by Shareholders
Shareholders should read the Notice and this Explanatory Memorandum carefully before
deciding how to vote on the Resolutions.
2.1 Proxies
A Proxy Form is attached to the Notice. This is to be used by Shareholders if they wish to
appoint a representative (a proxy) to vote in their place. All Shareholders are invited and
encouraged to participate in the Meeting, and are encouraged to lodge a directed Proxy Form
to the Company in accordance with the instructions thereon. Lodgement of a Proxy Form
will not preclude a Shareholder from attending and voting at the Meeting in person.
Please note that:
(a) a member of the Company entitled to attend and vote at the Meeting is entitled to
appoint a proxy;
(b) a proxy need not be a member of the Company; and
(c) a member of the Company entitled to cast two or more votes may appoint two proxies
and may specify the proportion or number of votes each proxy is appointed to
exercise, but where the proportion or number is not specified, each proxy may
exercise half of the votes.
Shareholders and their proxies should be aware that:
(a) If proxy holders vote, they must cast all directed proxies as they are directed to; and
(b) Any directed proxies which are not voted will automatically default to the Chair, who
must vote the proxies as directed.
Further details are set out below.
Proxy vote if appointment specifies way to vote
Section 250BB(1) of the Corporations Act provides that an appointment of a proxy may
specify the way the proxy is to vote on a particular resolution and, if it does:
8
(a) the proxy need not vote on a show of hands, but if the proxy does so, the proxy must
vote that way (i.e. as directed); and
(b) if the proxy has 2 or more appointments that specify different ways to vote on the
resolution – the proxy must not vote on a show of hands; and
(c) if the proxy is the Chair of the meeting at which the resolution is voted on – the proxy
must vote on a poll, and must vote that way (i.e. as directed); and
(d) if the proxy is not the Chair – the proxy need not vote on the poll, but if the proxy does
so, the proxy must vote that way (i.e. as directed).
Transfer of non-chair proxy to Chair in certain circumstances
Section 250BC of the Corporations Act provides that, if:
(a) an appointment of a proxy specifies the way the proxy is to vote on a particular
resolution at a meeting of the Company's members; and
(b) the appointed proxy is not the Chair of the meeting; and
(c) at the meeting, a poll is duly demanded, or is otherwise required under section
250JA,on the question that the resolution be passed; and
(d) either of the following applies:
(i) if a record of attendance is made for the meeting - the proxy is not recorded
as attending;
(ii) the proxy does not vote on the resolution,
the Chair of the meeting is taken, before voting on the resolution closes, to have been
appointed as the proxy for the purposes of voting on the resolution at the meeting.
The enclosed Proxy Form provides further details on appointing proxies and lodging Proxy
Forms.
2.2 Proxy Holders and Voting Instructions
If the Chair is appointed as your proxy and the Chair is not directed how to vote, you are
authorising the Chair to cast your undirected vote on all proposed resolutions.
If a member of the Company’s Key Management Personnel, or a Closely Related Party of
such member, is appointed as your proxy, they will not be able to vote your proxy on
Resolution 5 unless you direct them on how to do so.
If you intend to appoint a member of the Company’s Key Management Personnel, or a
Closely Related Party of such member, or the Chair, as your proxy, you are encouraged to
direct them how to vote on Resolution 5 by marking “For”, “Against” or “Abstain” for each of
those resolutions.
9
2.3 Submit your Proxy Vote
2.3.1 Online
Vote online at www.investorvote.com.au and simply follow the instructions on the enclosed
proxy form.
2.3.2 By Paper
If you do not wish to vote online, then it is necessary to complete in accordance with the
detailed instructions set out on the enclosed Proxy Form.
The return of your completed form (ONLY if you do NOT vote online) can be done by one of
the following ways:
BY MAIL: Computershare Investor Services Pty Limited
GPO Box 242
Melbourne VIC 3001
Australia
BY FAX: 1800 783 447 within Australia
+61 3 9473 2555 outside Australia
BY MOBILE: Using the QR Code on the Proxy Form
3. Resolution1 – Approval to issue Consideration Shares
3.1 Background
On 26 November 2025, the Company announced that it had entered into a binding acquisition
agreement (Acquisition Agreement) to acquire 100% of the issued capital in Reliis Pty Ltd
(Reliis) from the shareholders of Reliis (Vendors) (Acquisition).
The material terms of the Acquisition Agreement are set out in Schedule 2.
Further details regarding the Acquisition are available in the Company’s announcement to
ASX on 26 November 2025.
3.2 General
Resolution 1 seeks Shareholder approval pursuant to Listing Rule 7.1 for the issue of up to
110,000,000 Consideration Shares.
Resolution 1 is subject to and conditional upon all the Acquisition Resolutions being passed
by Shareholders.
3.3 Listing Rule 7.1
Listing Rule 7.1 limits the amount of equity securities that a listed company can issue without
approval of its shareholders over any 12 month period to 15% of the fully paid ordinary
securities it had on issue at the start of that 12 month period.
The issue of the Consideration Shares falls within exception 17 of Listing Rule 7.2, as the
Acquisition Agreement notes the issue of the Consideration Shares is subject to the Company
obtaining prior Shareholder approval. Exception 17 under Listing Rule 7.2 provides that if the
issue of any securities requires prior shareholder approval, then such issue is not counted
10
towards the 15% limit in Listing Rule 7.1. Accordingly, the Company is seeking Shareholder
approval under Listing Rule 7.1 for the issue of the Consideration Shares.
3.4 Technical information required by Listing Rule 14.1A
If Resolution 1 is passed (and all the Acquisition Resolutions are passed by Shareholders),
the Consideration Shares will be excluded in calculating the Company’s 15% limited in Listing
Rule 7.1, effectively increasing the number of equity securities the Company can issue
without Shareholder approval over the 12 month period following the date of issue of the
Consideration Shares.
If Resolution 1 is not passed, the Company will not be able to proceed with the issue of the
Consideration Shares, and the Company will need to consider alternative forms of payment
in lieu of such issue.
3.5 Technical information required by Listing Rule 7.5
Pursuant to and in accordance with Listing Rule 7.5, the following information is provided in
relation to Resolution 1:
(a) the Consideration Shares will be issued to the Vendors (and/or their respective
nominees);
(b) in accordance with paragraph 7.2 of Guidance Note 21, the Company confirms that
none of the Vendors being issued the Consideration Shares are:
(i) related parties of the Company, members of the Company’s Key Management
Personnel, substantial holders of the Company, advisers of the Company or
an associate of any of these parties; and
(ii) issued more than 1% of the issued capital of the Company at the time of issue,
(c) the maximum number of Consideration Shares to be issued is 110,000,000;
(d) the Consideration Shares issued will be fully paid ordinary shares in the capital of the
Company issued on the same terms and conditions as the Company’s existing
Shares;
(e) the Consideration Shares will be issued no later than three (3) months after the date
of the Meeting (or such later date to the extent permitted by any ASX waiver or
modification of the Listing Rules) and it is intended that issue of all the Consideration
Shares will occur on the same date;
(f) the Consideration Shares are being issued as consideration for the Acquisition.
Accordingly, no funds are being raised for the issue of the Consideration Shares;
(g) the purpose of the issue of the Consideration Shares is as consideration to the
Vendors (and/or their respective nominees) pursuant to the Acquisition Agreement;
(h) the Consideration Shares are being issued pursuant to the Acquisition Agreement. A
summary of the material terms of the Acquisition Agreement is included at Schedule
2;
(i) the Consideration Shares are not being issued under, or to fund, a reverse takeover;
and
(j) a voting exclusion statement is included in respect of Resolution 1 of this Notice.
11
3.6 Board recommendation
The Board believes that Resolution 1 is in the best interest of the Company and its
Shareholders and unanimously recommend that the Shareholders vote in favour of these
Resolution. The Chair intends to vote undirected proxies in favour of Resolution 1.
4. Resolution 2 – Approval to issue Performance Rights
4.1 General
Resolution 2 seeks Shareholder approval pursuant to Listing Rule 7.1 for the issue of up to
70,000,000 Performance Rights (in various classes and subject to vesting conditions) to
those Vendors who are who are major shareholders of Reliis (Majority Vendors) (and/or
their respective nominees).
Resolution 2 is subject to and conditional upon all the Acquisition Resolutions being passed
by Shareholders.
4.2 Listing Rule 7.1
A summary of Listing Rule 7.1 is set out in Section 3.2 above.
The proposed issue of the Performance Rights falls within exception 17 of Listing Rule 7.2,
as the Acquisition Agreement notes the issue of the Performance Rights is subject to the
Company obtaining prior Shareholder approval. Exception 17 under Listing Rule 7.2 provides
that if the issue of any securities require prior shareholder approval, then such issue is not
counted towards the 15% limit in Listing Rule 7.1. Accordingly, the Company is seeking
Shareholder approval under Listing Rule 7.1 for the issue of the Performance Rights.
4.3 Technical information required by Listing Rule 14.1A
If Resolution 2 is passed (and all the Acquisition Resolutions are passed by Shareholders),
the Company will be able to proceed with the issue of the Performance Rights. In addition,
the issue of the Performance Rights will be excluded from the calculation of the number of
equity securities that the Company can issue without Shareholder approval under Listing
Rule 7.1.
If Resolution 2 is not passed, the Company will not be able to proceed with the issue of the
Performance Rights, and the Company will need to consider alternative forms of payment in
lieu of such issue.
4.4 Technical information required by Listing Rule 7.3
Pursuant to and in accordance with Listing Rule 7.3, the following information is provided in
relation to Resolution 2:
(a) the Performance Rights will be issued to the Majority Vendors (and/or their respective
nominees);
(b) in accordance with paragraph 7.2 of Guidance Note 21, the Company confirms that
none of the Majority Vendors are:
(i) related parties of the Company, members of the Company’s Key Management
Personnel, substantial holders of the Company, advisers of the Company or
an associate of any of these parties; and
12
(ii) issued more than 1% of the issued capital of the Company at the time of issue,
(c) the maximum number of Performance Rights to be issued is 70,000,000 (comprising
of 40,000,000 Class A Performance Rights and 30,000,000 Class B Performance
Rights);
(d) a summary of the full terms and conditions of the Performance Rights are set out in
Schedule 3;
(e) the Performance Rights will be issued no later than three (3) months after the date of
the Meeting (or such later date to the extent permitted by any ASX waiver or
modification of the Listing Rules) and it is intended that issue of all the Performance
Rights will occur on the same date;
(f) the Performance Rights are being issued as part-consideration under the Acquisition
Agreement. Accordingly, no funds are being raised for the issue of the Performance
Rights;
(g) the purpose of the issue of the Performance Rights is as part-consideration to the
Majority Vendors pursuant to the Acquisition Agreement;
(h) the Performance Rights are being issued pursuant to the Acquisition Agreement. A
summary of the material terms of the Acquisition Agreement is included at Schedule
2;
(i) the Performance Rights are not being issued under, or to fund, a reverse takeover;
and
(j) a voting exclusion statement is included in respect of Resolution 2 of this Notice.
4.5 Board recommendation
The Board believes that Resolution 2 is in the best interest of the Company and its
Shareholders and unanimously recommend that the Shareholders vote in favour of
Resolution 2. The Chair of the meeting intends to vote undirected proxies in favour of
Resolution 2.
5. Resolution 3 – Approval of Convertible Notes and issue of
Shares (on conversion)
5.1 General
Pursuant to the Acquisition Agreement, the Company has agreed, subject to Shareholder
approval, to accept the novation and assume 100% of the obligations under Reliis’ convertible
note deed dated on or around 6 November 2025 (Convertible Notes) between Reliis and
various sophisticated and professional lenders (Noteholders) to issue up to a total of
25,000,000 convertible notes with a total face value of A$300,000 (based on a conversion
price of A$0.012 each).
The material terms of the Convertible Notes are set out below:
(a) (Principal Sum):
Share your feedback
Discover